Tamoxifen Protects from Vesicular Stomatitis Virus Infection

Volume: 12, Issue: 4, Pages: 142 - 142
Published: Sep 20, 2019
Abstract
Tamoxifen (TAM) is an estrogen-receptor antagonist, widely used in the adjuvant treatment of early stage estrogen-sensitive breast cancer. Several studies have revealed new biological targets of TAM that mediate the estrogen receptor independent activities of the drug. Recently, the antiviral activity of TAM on replication of human immunodeficiency virus (HIV), hepatitis C virus (HCV) and Herpes simplex virus (HSV-1) in vitro was described....
Paper Details
Title
Tamoxifen Protects from Vesicular Stomatitis Virus Infection
Published Date
Sep 20, 2019
Volume
12
Issue
4
Pages
142 - 142
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.